Category Archives: Cancer and neoplasms
Cancer and neoplasms
Ukrainian migrants’ and war refugees’ admissions to hospital: evidence from the Polish Nationwide General Hospital Morbidity Study, 2014–2022
Nov
Baseline data review According to the NGHMS, 13,024 Ukrainian citizens were admitted to Polish hospitals (except for psychiatric facilities) in the analysed period, including 5,676 men and 7,348 women. 6,728 persons (51.7%) were admitted to hospital after the outbreak of war (24.02.2022), including 2534 men and 4194 women (Table 1). Table 1 General characteristics of […]
Cancer and neoplasms
U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer
Nov
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov 20, 2023– Foundation Medicine Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® CDx to be used as a companion diagnostic for AstraZeneca’s Truqap ™ (capivasertib) in combination with Faslodex ® (fulvestrant) which has been contemporaneously approved for the treatment of adult […]
Cancer and neoplasms
Resection of the primary tumor improves the prognosis of gastrointestinal neuroendocrine neoplasms with liver metastases: mutual validation based on SEER database and institutional data
Nov
Pavel M, Oberg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844–60. Article CAS PubMed Google Scholar Oberg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol. 2010;21(Suppl 7):vii72–80. Article PubMed Google Scholar Eto K, Yoshida N, Iwagami S, Iwatsuki M, […]
Cancer and neoplasms
Delay in diagnosis to treatment and impact on survival of gastric adenocarcinoma in a low income setting without screening facility
Nov
Abstract The treatment modality of gastric adenocarcinoma (GCA) depends on the stage of the disease at the clinical presentation. Long delays are probably an unfavorable factor for the patient’s prognosis. A prospective longitudinal, study involving 145 consecutive GCA was conducted at the National Hospital of Sri Lanka (NHSL). The overall delay (in weeks) was recorded […]
Nov
Sponsored content Today, it is increasingly difficult to find a person who has never traveled abroad. Tourism is growing rapidly and so is medical tourism. If the level of medicine in your country is low, you no longer need to be treated in your home country, risking your health, suffering pain and not having confidence […]
Nov
Copyright © AFP 2017-2023. All rights reserved. A video spreading across social media links the high rate of deaths reported with unknown causes in Alberta in 2021 to Covid-19 vaccines. There is no evidence for this; no deaths attributed to the jabs were reported in the Canadian province that year. “‘Cause unknown’ is a crime […]
Nov
“Because the patient’s condition may affect their treatment preferences, clinicians should reconfirm their interest in receiving secondary findings, document the preference in the electronic medical record, and time this disclosure appropriately,” according to Stacy W. Gray, MD. Administering pre-test discussions and adequately preparing patients for unanticipated, inheritable genetic findings prior to tumor sequencing showed significant […]
Nov
Alladapt Immunotherapeutics, Inc., has received FDA Fast Track Designation for ADP101, its investigational multi-food oral immunotherapy designed to treat allergy to 1 or more significant food allergens. According to a press release from the company, ADP101 is the most advanced multi-food oral immunotherapy pharmaceutical candidate in development.1 The Fast Track Designation provides FDA endorsement for […]